The effect of the aromatase inhibitor, rogletimide (pyridoglutethimide), on guinea pig adrenal cell steroidogenesis and placental microsomal aromatase activity: Comparison with aminoglutethimide and CGS 16949A

This publication has 12 references indexed in Scilit:

• POTENCY AND SELECTIVITY OF THE NON-STEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST CANCER PATIENTS
  Clinical Endocrinology, 1990
• Analogs of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents
  Journal of Medicinal Chemistry, 1987
• In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A
  Steroids, 1987
• Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue
  The Journal of Steroid Biochemistry and Molecular Biology, 1986
• On the Assessment of the in Vitro Biopotency and Site(s) of Action of Drugs Affecting Adrenal Steroidogenesis
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986
• A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients
  British Journal of Cancer, 1985
• Analogs of aminoglutethimide: selective inhibition of aromatase
  Journal of Medicinal Chemistry, 1985
• EFFECTS OF AMINOGLUTETHIMIDE ON ADRENAL STEROID SECRETION
  Clinical Endocrinology, 1983
• Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer
  British Journal of Cancer, 1983
• Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic Trial
  Journal of Clinical Endocrinology & Metabolism, 1967